[HLA-DRB1 gene distribution in Croatian arthritis patients]

Nadica Laktasić Zerjavić1, Dragica Soldo Juresa, Durdica Babić-Naglić

  • 1Klinika za reumatske bolesti i rehabilitaciju Medicinskog fakulteta Sveucilista u Zagrebu, KBC Zagreb.

Reumatizam
|May 13, 2006
PubMed

Insights

Certain HLA-DRB1 genes are linked to rheumatoid arthritis (RA) severity. This study found susceptible alleles in 64% of Croatian RA patients, guiding future monitoring for disease progression.

Area of Science:

  • Immunogenetics
  • Rheumatology

Context:

  • Rheumatoid arthritis (RA) is an autoimmune disease with variable clinical outcomes.
  • Genetic factors, particularly Human Leukocyte Antigen (HLA) genes, significantly influence RA susceptibility and severity.
  • The Shared Epitope hypothesis posits that specific HLA-DRB1 alleles are associated with increased RA risk and severity.

Purpose:

  • To determine the distribution of HLA-DRB1 alleles in a Croatian cohort of patients with various forms of arthritis.
  • To identify the frequency of susceptible HLA-DRB1 alleles associated with poor prognosis in rheumatoid arthritis.
  • To establish a baseline for monitoring disease progression in patients carrying these genetic markers.

Summary:

  • A study analyzed HLA-DRB1 alleles in 90 Croatian patients diagnosed with non-specific joint arthritis, non-erosive RA, and erosive RA using PCR-SSP.
  • Susceptible HLA-DRB1 alleles, known indicators of potential disease severity, were identified in 58 (64.44%) patients.
  • The most prevalent susceptible alleles were DRB1*0101 (43.33%), DRB1*0401 (17.77%), and DRB1*0404 (10%).

Impact:

  • This research provides crucial data on HLA-DRB1 allele frequencies within the Croatian population, aiding in personalized risk assessment for rheumatoid arthritis.
  • Identifying patients with susceptible alleles allows for closer monitoring and potentially earlier intervention to mitigate severe disease progression.
  • Findings support the role of specific HLA-DRB1 genotypes as prognostic indicators in rheumatoid arthritis, informing clinical management strategies.